Prognostic impact of isolated tumor cells and micrometastases in axillary lymph nodes of breast cancer patients

Breast Disease

Volumn 31, Issue 2, 2010, Pages 107-113

  Tjan Heijnen, Vivianne C G ^a   Pepels, Manon J ^a   De Boer, Maaike ^a,b  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CELL ISOLATION; CLINICAL DECISION MAKING; COMPARATIVE EFFECTIVENESS; DISEASE FREE SURVIVAL; DISTANT METASTASIS; EARLY CANCER; FOLLOW UP; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE DISSECTION; LYMPH NODE IRRADIATION; LYMPH NODE METASTASIS; MICROMETASTASIS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK; RISK FACTOR; SENTINEL LYMPH NODE BIOPSY; SURVIVAL RATE; TUMOR CELL;

AXILLA; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; NEOPLASTIC CELLS, CIRCULATING; PROGNOSIS; RISK; SENTINEL LYMPH NODE BIOPSY; SURVIVAL ANALYSIS;

EID: 79952672692     PISSN: 08886008     EISSN: 15581551     Source Type: Journal    
DOI: 10.3233/BD-2010-0302     Document Type: Article

References (26)

1. B. Fisher, M. Bauer, D.L. Wickerham et al., Relation ofnum-ber ofpositive axillary nodes to the prognosis ofpatients with primary breast cancer. An NSABP update, Cancer 52 (1983), 1551-1557. (Pubitemid 13018271)
2. G. Cserni, I. Amendoeira, N. Apostolikas et al., Pathological work-up of sentinel lymph nodes in breast cancer. Review of current datato be considered forthe formulation ofguidelines, Eur J Cancer 39 (2003), 1654-1667. (Pubitemid 36897601)
3. M.J. Bolster, P. Bult, R.F. Schapers et al., Differences in sen-tinel lymph node pathology protocols lead to differences in surgical strategy in breast cancer patients, Ann Surg Oncol 13 (2006), 1466-1473. (Pubitemid 44749658)
4. Green: AJCC cancer staging manual. 6th ed. Chicago, Amer-ican Joint Commission on Cancer (2002).
5. M. de Boer, J.A. van Dijck, P. Bult et al., Breast cancer prog-nosis and occult lymph node metastases, isolated tumor cells, and micrometastases, J Natl Cancer Inst 102 (2010), 410-425.
6. W.C. Liang, B.J. Sickle-Santanello and T.A. Nims, Is a com-pletion axillary dissection indicated for micrometastases in the sentinel lymphnode? Am J Surg 182 (2001), 365-368. (Pubitemid 33079088)
7. A. Chagpar, L.P. Middleton, A.A. Sahin et al., Clinical out-come of patients with lymph node-negative breast carcinoma who have sentinel lymph node micrometastases detected by immunohistochemistry, Cancer 103 (2005), 1581-1586. (Pubitemid 40490018)
8. Y.G. Fan, Y.Y. Tan, C.T. Wu et al., The effect ofsentinel node tumor burden on non-sentinel node status and recurrence rates in breast cancer, Ann Surg Oncol 12 (2005), 705-711.
9. N.K. Soni and A.J. Spillane, Experience ofsentinel node biopsy alone in early breast cancer without further axillary dissection in patients with negative sentinel node, ANZ J Surg 75 (2005), 292-299. (Pubitemid 40826893)
10. S. Imoto, A. Ochiai, C. Okumura et al., Impact of isolated tumor cells in sentinel lymph nodes detected by immunohistochemical staining, Eur J Surg Oncol 32 (2006), 1175-1179. (Pubitemid 44774413)
11. T. Nagashima, M. Sakakibara, S. Nakano et al., Sentinel node micrometastasis and distant failure in breast cancer patients, Breast Cancer 13 (2006), 186-191.
12. L. Ryden, G. Chebil, L. Sjostrom et al., Determination of sentinel lymph node (SLN) status in primary breast cancer by prospective use of immunohistochemistry increases the rate ofmicrometastases and isolated tumour cells: analysis of 174 patients after SLNbiopsy, Eur J Surg Oncol 33 (2007), 33-38. (Pubitemid 46131884)
13. M.S. Pugliese, J.D. Beatty, R.J. Tickman et al., Impact and outcomes of routine microstaging of sentinel lymph nodes in breast cancer: significance of the pN0(i+) and pN1mi categories, Ann Surg Oncol 16 (2009), 113-120.
14. C.E. Cox, J.V. Kiluk, A.I. Riker et al., Significance ofsentinel lymph node micrometastases in human breast cancer, J Am Coll Surg 206 (2008), 261-268.
15. P.D. Gobardhan, S.G. Elias, E.V. Madsen et al., Prognostic value of micrometastases in sentinel lymph nodes of patients with breast carcinoma: a cohort study, Ann Oncol 20 (2009), 41-48.
16. J. Reed, M. Rosman, K.M. Verbanac et al., Prognostic impli-cations ofisolated tumor cells and micrometastases in sentinel nodes ofpatients with invasive breast cancer: 10-year analysis of patients enrolled in the prospective East Carolina Univer-sity/Anne Arundel Medical Center Sentinel Node Multicenter Study, J Am Coll Surg 208 (2009), 333-340.
17. E. Montagna, G. Viale, N. Rotmensz et al., Minimal axillary lymph node involvement in breast cancer has different prog-nostic implications according to the staging procedure, Breast Cancer Res Treat 118 (2009), 385-394.
18. M. Colleoni, N. Rotmensz, G. Peruzzotti et al., Size ofbreast cancer metastases in axillary lymph nodes: clinical relevance ofminimal lymph node involvement, J Clin Oncol 23 (2005), 1379-1389.
19. N.M. Hansen, B. Grube, X. Ye et al., Impact ofmicrometas-tases in the sentinel node ofpatients with invasive breast can-cer, J Clin Oncol 27 (2009), 4679-4684.
20. P.J. van Diest, M. de Boer, C.H. van Deurzen et al., Mi-crometastases and isolated tumor cells in breast cancer are indeed associated with poorer outcome, J Clin Oncol 28(e140; authorreplye)(2010), 141-142.
21. D.E. Gyorki and M.A. Henderson, Significance of sentinel lymph node micrometastases in patients with breast cancer, J Clin Oncol 28 (e139; author reply e) (2010), 141-142.
22. M.H. Leidenius, J.H. Vironen, P.S. Heikkila et al., Influence of isolated tumor cells in sentinel nodes on outcome in small, node-negative (pT1N0M0) breast cancer, Ann Surg Oncol 17, 254-262.
23. Y. Andersson, J. Frisell, M. Sylvan et al., Breast cancer sur-vival in relation to the metastatic tumor burden in axillary lymph nodes, J Clin Oncol 28 (2010), 2868-2873.
24. M. de Boer, C.H. van Deurzen, J.A. van Dijck et al., Mi-crometastases or isolatedtumor cells andthe outcome ofbreast cancer,NEngl JMed361 (2009), 653-663.
25. G.P. Kuijt, A.C. Voogd, L.V. van de Poll-Franse, L.J. Schei-jmans, M.W. van Beek and R.M. Roumen, The prognostic significance ofaxillary lymph-node micrometastases in breast cancer patients, Eur J Surg Oncol 31(5) (2005), 500-505. (Pubitemid 40724091)
26. S.P. Harlow, D.N. Krag, T.B. Julian et al., Prerandomization Surgical Training for the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-32 trial: a randomized phase III clinical trial to compare sentinel node resection to con-ventional axillary dissection in clinically node-negative breast cancer, Ann Surg 241 (2005), 48-54. (Pubitemid 40040991)